For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
9
views
0
references
 Top references
cited by
20
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To report the protocol of a trial designed to evaluate the efficacy, safety and mechanism of action of low-dose atropine (0.01%) eye-drops for reducing progression of myopia in UK children.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Br J Ophthalmol
          Title: The British journal of ophthalmology
          Publisher: BMJ
          ISSN (Electronic): 1468-2079
          ISSN (Print): 0007-1161
          Publication date (Electronic): July 2020
          Volume: 104
          Issue: 7
          Affiliations
          [1 ] Centre for Public Health, Queen's University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK a.azuara-blanco@qub.ac.uk.
          [2 ] School of Life & Health Sciences, Aston University, Birmingham, UK.
          [3 ] Department of Vision Sciences, Glasgow Caledonian University, Glasgow, UK.
          [4 ] School of Biomedical Sciences, Ulster University, Coleraine, UK.
          [5 ] Department of Optometry and Ophthalmic Dispensing, Anglia Ruskin University, Cambridge, UK.
          [6 ] NICTU, Belfast Health and Social Care Trust, Belfast, UK.
          [7 ] Centre for Public Health, Queen's University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK.
          [8 ] Department of Pharmacy, Belfast Health and Social Care Trust, Belfast, UK.
          [9 ] Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
          [10 ] Optometry Department, Dublin Institute of Technology, Dublin, Ireland.
          [11 ] Department of Ophthalmology, Childrens University Hospital, Dublin, Ireland.
          [12 ] Centre for Ophthalmology and Visual Science, University of Western Australia, Lions Eye Institute, Perth, Western Australia, Australia.
          [13 ] Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
          [14 ] Department of Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangdong, China.
          [15 ] Orbis International, New York, United States.
          Article
          Publisher Item ID: bjophthalmol-2019-314819
          DOI: 10.1136/bjophthalmol-2019-314819
          PubMed ID: 31653669
          SO-VID: b601bb18-cd20-4f0f-a837-da2ad6c8aa21
          Copyright © © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
          History

          Keywords: child health (paediatrics),clinical trial,drugs,optics and refraction,treatment medical
          Data availability:
          Keywords: child health (paediatrics), clinical trial, drugs, optics and refraction, treatment medical

          Comments

          Comment on this article